Search clinical trials for: malignant lesions

Total 7594 results

Eli Lilly and Company

Approved for marketing

ALIMTA (Pemetrexed) Alone or in Combination With Cisplatin for Patients With Malignant Mesothelioma.

Mesothelioma

United States, Brazil, Egypt, Saudi Arabia
Postgraduate Institute of Medical Education and...

Unknown

A Comparative Study of the Safety and Efficacy of Face Talc Slurry and Iodopovidone for Pleurodesis

Primary Spontaneous Pneumothorax | Malignant Pleural Effusions | Recurrent Pleural Effusions | Secondary Spontaneous Pneumothorax

India
Assistance Publique - Hôpitaux de Paris

Completed

Radiotherapy for Malignant Astrocytomas in the Elderly

Glioblastoma Multiforme | Anaplastic Astrocytoma | Primary Brain Tumor

France
Eli Lilly and Company

Completed

A Study of LY317615 in Patients With Brain Tumors

Malignant Glioma

United States
Eli Lilly and Company

Completed

A Study Comparing Pemetrexed Plus Best Supportive Care Versus Best Supportive Care Alone in the Treatment of Mesothelioma

Mesothelioma

Canada
Eli Lilly and Company

Completed

Pemetrexed Plus Gemcitabine as Front-Line Chemotherapy for Patients With Malignant Pleural or Peritoneal Mesothelioma

Mesothelioma

United States
Celgene Corporation

Completed

Phase I Trial of CC-8490 for the Treatment of Subjects With Recurrent/Refractory High-Grade Gliomas

Glioblastoma | Malignant Gliomas

United States
National Institute of Arthritis and Musculoskeletal...

Completed

Treatment of Psoriasis With Parathyroid Hormone

Plaque Psoriasis

United States
National Taiwan University Hospital

Unknown

Comparison of the Human Papillomavirus (HPV) Type 16 E7-Specific Immune Response Between a Normal Population and Patients With Cervical Lesions

Cervical Cancer

Taiwan
Wyeth is now a wholly owned subsidiary of Pfizer

Terminated

Study Evaluating MST-997 in Advanced Malignant Solid Tumors

Neoplasms

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Terminated

Study Evaluating MST-997 in Advanced Malignant Solid Tumors

Neoplasms

United States
Novalar Pharmaceuticals, Inc.

Completed

Study of NV-101 for Efficacy, Pharmacodynamics, and Safety in Dental Patients Undergoing Mandibular Procedures

Anesthesia, Dental

United States
Rigshospitalet, Denmark

Unknown

Hypercoagulability and Thromboembolic Risk in Patients With Malignant Disease, Evaluated by Thrombelastograph (TEG®)

Cancer

Denmark
Pfizer

Completed

Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia

Neoplasms | Multiple Myeloma | Lymphoma, Malignant | Thrombocytopenia

United States, Argentina, Mexico
University of Sao Paulo
Fundação de Amparo à Pesquisa do Estado de São Paulo

Completed

Optical Coherence Tomography Measurements in Eyes With Band Atrophy

Vision Disorders
GammaCan

Unknown

IVIG in the Treatment of Metastatic Cancers of the Prostate, Colon and Melanoma

Malignant Melanoma | Urologic Cancer | Cancer of Colon

Israel
University Health Network, Toronto
Bausch Health Americas, Inc.

Unknown

Use of the Cannabinoid Nabilone for the Promotion of Sleep in Chronic, Non-Malignant Pain Patients

Pain | Insomnia

Canada
Assistance Publique - Hôpitaux de Paris

Terminated

Comparison of 2 Antifungal Treatment (Empirical Versus Pre-Empirical) Strategies in Prolonged Neutropenia

Malignant Hemopathy | Duration of Neutropenia Following Chemotherapy > 10 Days

France
Cytos Biotechnology AG

Completed

Safety and Immunogenicity of a Melan-A VLP Vaccine in Advanced Stage Melanoma Patients

Malignant Melanoma

Switzerland
Purdue Pharma LP

Terminated

Efficacy and Safety of Hydromorphone Hydrochloride Extended-Release Compared to Placebo in Subjects With Persistent Pain

Chronic Non-Malignant Pain

United States
Julius-Maximilians University

Unknown

Survivin Peptide Vaccination for Patients With Advanced Melanoma, Pancreatic, Colon and Cervical Cancer

Cervical Cancer | Pancreatic Cancer | Colon Cancer | Malignant Melanoma

Germany
Northern California Melanoma Center
Bayer; Melanoma Research Institute

Completed

GM-CSF as Adjuvant Therapy of Melanoma

Malignant Melanoma

United States
Dermatologic Cooperative Oncology Group

Unknown

Standard Palliative Care Versus Standard Palliative Care Plus Polychemotherapy in Metastasized Malignant Melanoma

Metastatic Melanoma

Germany
Novartis
QLT Inc.

Completed

Photodynamic Therapy in Occult-Only Lesions (POOL)

Age-Related Macular Degeneration

Switzerland
Dermatologic Cooperative Oncology Group

Unknown

Standard High-Dose Alpha Interferon Versus Intermittent High-Dose Alpha Interferon

Therapy | Adjuvant | Stage III Malignant Melanoma | Interferon Alpha

Germany
University of British Columbia
Vancouver Coastal Health Research Institute; 3M

Completed

Safety and Efficacy of Imiquimod Applied in Dose-Cycle for Actinic Keratoses

Actinic Keratoses

Canada
William Beaumont Hospitals
Rhone-Poulenc Rorer

Completed

LV Thrombus Pilot Study for Comparing Enoxaparin Vs. Warfarin

Coronary Artery Disease | Acute Myocardial Infarction

United States
Taichung Veterans General Hospital
Ton General Hospital

Unknown

Comparison the Level of CTGF Protein and Related Cytokine in Pleural Effusion

Tuberculosis | Empyema | Malignant Pleural Effusion | Tuberculous Pleurisy

China
National Health Research Institutes, Taiwan

Unknown

A Pathology Reference Laboratory for the Study of Infectious Diseases and Malignant Lymphoma

Lymphoma

Taiwan
Fachklinik Hornheide an der Universität Münster

Unknown

Efficacy of Chemotherapy Combined With Regional Hypothermia in Advanced Malignant Melanoma Patients With Progressive Soft Tissue Metastases

Advanced Metastastic Malignant Melanoma | Refractory to First-Line Chemotherapy Irresectable Progressive Soft Tissue Metastases

Germany
Rambam Health Care Campus
Lumenis Be Ltd.

Unknown

Evaluation and Optimization of the Technical and Clinical Performance of the Lumenis ONE Platform

Port Wine Stain | Telangiectases

Israel
BioWest Therapeutics Inc

Completed

Safety and Efficacy of MBI 226 1.25% and 2.5% Topical Acne Solutions in the Treatment of Acne

Acne Vulgaris | Acne | Propionibacterium Acnes
BioWest Therapeutics Inc

Completed

Safety and Efficacy of MBI 226 2.5% and 5.0% Topical Acne Solutions in the Treatment of Acne

Acne Vulgaris | Acne | Propionibacterium Acnes
Orthopaedic Research Foundation
Genzyme, a Sanofi Company

Completed

Autologous Chondrocyte Implantation in the Patellofemoral Joint

Chondrosis | Patellar Articular Cartilage Lesions | Trochlear Articular Cartilage Lesions

United States
National Taiwan University Hospital

Unknown

Expression of VEGF-C and VEGF-CR in Oral Cancers and Premalignant Lesions

Oral Cancer

Taiwan
Rigshospitalet, Denmark

Completed

Sirolimus Eluting Stents in Complex Coronary Lesions (SCANDSTENT)

Ischaemic Heart Disease

Denmark
Gustave Roussy, Cancer Campus, Grand Paris

Terminated

Rhabdomyosarcoma and Malignant Soft Tissue Tumours of Childhood

Rhabdomyosarcoma | Malignant Soft Tissue

France
Titan Pharmaceuticals

Terminated

A Pilot Study of Pivanex in Patients With Malignant Melanoma

Malignant Melanoma

United States
FeRx

Completed

Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver

Melanoma | Sarcoma | Stomach Neoplasms | Gastrointestinal Neoplasms | Breast Neoplasms | Lung Neoplasms | Liver Neoplasms | Colorectal Neoplasms | Pancreatic Neoplasms | Esophageal Neoplasms | Metastases, Neoplasm | Cholangiocarcinoma

United States, Germany
Celgene Corporation

Completed

Study to Compare the Efficacy and Safety of Two CC-5013 Dose Regimens in Subjects With Metastatic Malignant Melanoma

Melanoma | Neoplasm Metastasis

United States, Canada
CancerVax Corporation

Unknown

Vaccine Therapy for Patients With Stage III Melanoma

Malignant Melanoma

United States, France, Australia, Canada, Germany, United Kingdom, Switzerland, Brazil, Ireland, Israel, Italy, Netherlands, New Zealand
CancerVax Corporation

Unknown

Vaccine Therapy for Patients With Stage IV Melanoma

Malignant Melanoma

United States, France, Australia, Canada, Germany, Switzerland, Brazil, Ireland, Israel, Italy, Netherlands, New Zealand, United Kingdom
National Center for Research Resources (NCRR)
Icahn School of Medicine at Mount Sinai

Completed

Genetic Study of Patients and Families With Diaphyseal Medullary Stenosis With Malignant Fibrous Histiocytoma of the Bone

Stenosis | Histiocytoma

United States
Chiron Corporation

Completed

A Phase I Study of the Safety of Proleukin (Aldesleukin) in Combination With Ganciclovir and Antiretroviral Therapy in HIV Seropositive Patients With Cytomegalovirus (CMV) Retinitis

HIV Infections | Cytomegalovirus Retinitis

United States

Search clinical trials for: malignant lesions

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Sweden

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations